Assessing the risk factors for difficult-to-treat depression and treatment-resistant depression

Journal of Clinical Psychiatry

Volumn 77, Issue , 2016, Pages 4-8

  Gaynes, Bradley ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ABSENTEEISM; ARTICLE; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIFFICULT TO TREAT DEPRESSION; DISEASE COURSE; DRUG RESPONSE; ENVIRONMENT; FINANCIAL MANAGEMENT; GENETIC VARIABILITY; HUMAN; JOB PERFORMANCE; MAINTENANCE THERAPY; MEDICAL FEE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT MONITORING; PRESENTEEISM; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; QUESTIONNAIRE; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SOCIAL ADAPTATION; SOCIAL STRESS; THERAPY RESISTANCE; TREATMENT REFUSAL; TREATMENT RESISTANT DEPRESSION; COST OF ILLNESS; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; PSYCHOLOGICAL RATING SCALE;

ANTIDEPRESSIVE AGENTS; COST OF ILLNESS; DEPRESSION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RISK FACTORS;

EID: 84959521526     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14077su1c.01     Document Type: Article

References (30)

1. World Health Organization. Depression: Fact Sheet No. 369. http://www. who.int/mediacentre/factsheets/fs369/en/. October 2012. Accessed July 10, 2015.
2. National Institute of Mental Health. Major depression with severe impairment among adults. http://www.nimh.nih.gov/health/statistics/prevalence/major-depression-with-severe-impairment-Among-Adults. shtml. Accessed June 19, 2015.
3. Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. Arlington, VA: American Psychiatric Association; 2010.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.
5. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-Term outcomes in depressed outpatients requiring one or several treatment steps: A STAR ∗D report. Am J Psychiatry. 2006;163(11): 1905-1917. doi: 10.176/api.ajp.163.1.1905 PubMed
6. Trevino K, McClintock SM, McDonald Fischer N, et al. Defining treatmentresistant depression: A comprehensive review of the literature. Ann Clin Psychiatry. 2014;26(3): 222-232. PubMed
7. Kupfer DJ. Long-Term treatment of depression. J Clin Psychiatry. 1991;52(suppl): 28-34. PubMed
8. Kroenke K, Spitzer RL. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9): 509-515. doi: 10.3928/048-5713-2020901-06
9. Carmody TJ, Rush AJ, Bernstein IH, et al. Making clinicians lives easier: Guidance on use of the QIDS self-report in place of the MADRS. J Affect Disord. 2006;95(1-3): 115-118. doi: 10.1016/j.jad.206.03.024 PubMed
10. Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16): 26-31. PubMed
11. Gaynes BN. Identifying difficult-To-Treat depression: Differential diagnosis, subtypes, and comorbidities. J Clin Psychiatry. 2009;70 (suppl 6): 10-15. doi: 10.408/JCP.813su1c.02 PubMed
12. Blanco C, Okuda M, Markowitz JC, et al. The epidemiology of chronic major depressive disorder and dysthymic disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2010;71(12): 1645-1656. doi: 10.408/JCP.09m0563gry PubMed
13. Fawcett J. Antidepressants: Partial response in chronic depression. Br J Psychiatry Suppl. 1994;26(26): 37-41. PubMed
14. Mrazek DA, Hornberger JC, Altar CA, et al. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatr Serv. 2014;65(8): 977-987. doi: 10.176/api.ps.2013059 PubMed
15. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9): 1501-1504. doi: 10.176/api.ajp.157.9.1501 PubMed
16. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3): 97-108. doi: 10.1016/S0165-0327(98)0138-4 PubMed
17. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: How did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12): 1465-1475. doi: 10.408/JCP.v64n121 PubMed
18. Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2): 155-162. doi: 10.408/JCP.14m09298 PubMed
19. Lepine BA, Moreno RA, Campos RN, et al. Treatment-resistant depression increases health costs and resource utilization. Rev Bras Psiquiatr. 2012;34(4): 379-388. doi: 10.1016/j.rbp.2012.05.09 PubMed
20. Petersen T, Papakostas GI, Mahal Y, et al. Psychosocial functioning in patients with treatment resistant depression. Eur Psychiatry. 2004;19(4): 196-201. doi: 10.1016/j.eurpsy.203.1.06 PubMed
21. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163(9): 1561-1568. doi: 10.176/api.ajp.163.9.1561 PubMed
22. Bennabi D, Aouizerate B, El-Hage W, et al. Risk factors for treatment resistance in unipolar depression: A systematic review. J Affect Disord. 2015;171: 137-141. doi: 10.1016/j.jad.2014.09.020 PubMed
23. Souery D, Oswald P, Massat I, et al, for the Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. J Clin Psychiatry. 2007;68(7): 1062-1070. doi: 10.408/JCP.v68n0713 PubMed
24. Kaplan MJ, Klinetob NA. Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatmentresistant depression. J Nerv Ment Dis. 2000;188(9): 596-601. doi: 10.1097/05053-2090-06 PubMed
25. Benton T, Staab J, Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry. 2007;19(4): 289-303. doi: 10.1080/10401230701653542 PubMed
26. Carey M, Small H, Yoong SL, et al. Prevalence of comorbid depression and obesity in general practice: A cross-sectional survey. Br J Gen Pract. 2014;64(620): E122-e127. doi: 10.39/bjgp14X67482 PubMed
27. Chen MH, Su TP, Chen YS, et al. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: A nationwide population-based study. BMC Psychiatry. 2013;13(1): 161. doi: 10.186/1471-24X-13-161 PubMed
28. Harvey PD. Cognitive impairments in major depression and bipolar disorders. Psychiatry (Edgmont). 2007;4(1): 12-14. PubMed
29. Papazacharias A, Nardini M. The relationship between depression and cognitive deficits. Psychiatr Danub. 2012;24(suppl 1): S179-S182. PubMed
30. Fabbri C, Porcelli S, Serretti A. From pharmacogenetics to pharmacogenomics: The way toward the personalization of antidepressant treatment. Can J Psychiatry. 2014;59(2): 62-75. PubMed